Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Enterprise Value of -$99.9 million for Q1 2026, down 102.72% on a YoY basis from $3.7 billion in Q1 2025, and up 9.85% sequentially from -$110.9 million in Q4 2025.
Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Enterprise Value data on file, last reported at -$99.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 102.72% year-over-year to -$99.9 million; the trailing twelve-month figure through Mar 2026 stood at -$99.9 million (down 102.72% YoY), and the FY2025 full-year result was -$110.9 million, down 73.12% from the prior year.
- Enterprise Value grew to -$99.9 million in Q1 2026, from -$110.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.5 million in Q3 2024 to a low of -$110.9 million in Q4 2025.
- A 4-year average of -$58.9 million and a median of -$50.5 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value soared 94.99% in 2024 and sank 2876.86% in 2025, its largest moves.
- Tracing CAMP's Enterprise Value over 4 years: stood at -$38.4 million in 2023, then tumbled by 66.86% to -$64.0 million in 2024, then tumbled by 73.12% to -$110.9 million in 2025, then rose by 9.85% to -$99.9 million in 2026.
- Business Quant data shows CAMP's Enterprise Value at -$99.9 million in Q1 2026, -$110.9 million in Q4 2025, and -$75.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -99.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.94 Mn |
| Dec 31, 2025 | -110.86 Mn |
| Sep 30, 2025 | -75.26 Mn |
| Jun 30, 2025 | -39.05 Mn |
| Mar 31, 2025 | -49.30 Mn |
| Dec 31, 2024 | -64.04 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Dec 31, 2023 | -38.38 Mn |
| Sep 30, 2023 | -50.47 Mn |